147 related articles for article (PubMed ID: 9274448)
1. Inhibition of telomerase activity by cisplatin in human testicular cancer cells.
Burger AM; Double JA; Newell DR
Eur J Cancer; 1997 Apr; 33(4):638-44. PubMed ID: 9274448
[TBL] [Abstract][Full Text] [Related]
2. Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines.
Cressey TR; Tilby MJ; Newell DR
Eur J Cancer; 2002 Mar; 38(4):586-93. PubMed ID: 11872354
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of telomerase activity in endometrial cancer cells by selenium-cisplatin conjugate despite suppression of its DNA-damaging activity by sodium ascorbate.
Błasiak J; Kadłubek M; Kowalik J; Romanowicz-Makowska H; Pertyński T
Teratog Carcinog Mutagen; 2002; 22(1):73-82. PubMed ID: 11754389
[TBL] [Abstract][Full Text] [Related]
4. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
[TBL] [Abstract][Full Text] [Related]
5. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
Mueller S; Hartmann U; Mayer F; Balabanov S; Hartmann JT; Brummendorf TH; Bokemeyer C
Invest New Drugs; 2007 Dec; 25(6):519-24. PubMed ID: 17534576
[TBL] [Abstract][Full Text] [Related]
6. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
[TBL] [Abstract][Full Text] [Related]
7. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
Zhang RG; Zhang RP; Wang XW; Xie H
Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
[TBL] [Abstract][Full Text] [Related]
8. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line.
Mese H; Ueyama Y; Suzuki A; Nakayama S; Sasaki A; Hamakawa H; Matsumura T
Chemotherapy; 2001; 47(2):136-42. PubMed ID: 11173816
[TBL] [Abstract][Full Text] [Related]
10. Correlation of telomerase activity and telomere length to chemosensitivity.
Kiyozuka Y
Methods Mol Med; 2005; 111():97-108. PubMed ID: 15911975
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E suppresses telomerase activity in ovarian cancer cells.
Bermudez Y; Ahmadi S; Lowell NE; Kruk PA
Cancer Detect Prev; 2007; 31(2):119-28. PubMed ID: 17335992
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA.
Bisoffi M; Chakerian AE; Fore ML; Bryant JE; Hernandez JP; Moyzis RK; Griffith JK
Eur J Cancer; 1998 Jul; 34(8):1242-9. PubMed ID: 9849487
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.
Kondo Y; Kondo S; Tanaka Y; Haqqi T; Barna BP; Cowell JK
Oncogene; 1998 Apr; 16(17):2243-8. PubMed ID: 9619833
[TBL] [Abstract][Full Text] [Related]
14. Effects of four chemotherapeutic agents, bleomycin, etoposide, cisplatin, and cyclophosphamide, on DNA damage and telomeres in a mouse spermatogonial cell line.
Liu M; Hales BF; Robaire B
Biol Reprod; 2014 Apr; 90(4):72. PubMed ID: 24571982
[TBL] [Abstract][Full Text] [Related]
15. Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples.
Faraoni I; Graziani G; Turriziani M; Masci G; Mezzetti M; Testori A; Veronesi U; Bonmassar E
Lab Invest; 1999 Aug; 79(8):993-1005. PubMed ID: 10462037
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
17. Synthetic 2'-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity.
Wan MS; Fell PL; Akhtar S
Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):309-17. PubMed ID: 9743468
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy.
Burger AM; Bibby MC; Double JA
Br J Cancer; 1997; 75(4):516-22. PubMed ID: 9052403
[TBL] [Abstract][Full Text] [Related]
19. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
[TBL] [Abstract][Full Text] [Related]
20. Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.
Asai A; Kiyozuka Y; Yoshida R; Fujii T; Hioki K; Tsubura A
Anticancer Res; 1998; 18(3A):1465-72. PubMed ID: 9673357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
